Skip to Main Content

Paper Details

Single-cell profiling of multiple myeloma reveals molecular response to FGFR3 inhibitor despite clinical progression.
Cold Spring Harb Mol Case Stud
0
2023
-, Chromosome 17p, FGFR1, FGFR1-4, FGFR3, MM, cancer, erdafitinib, multiple myeloma, mutant, mutant subclone, patient, patients, plasma cell malignancy, relapsed/refractory myeloma, t(, t(4;14), tumor
Author NameAffiliation
Zhihua LiPrincess Margaret Cancer Centre, University Health Network
Trevor J PughPrincess Margaret Cancer Centre, University Health Network
Trevor J PughOntario Institute for Cancer Research
Trevor J PughUniversity of Toronto
Trevor J PughPrincess Margaret Cancer Centre, University Health Network
Trevor J PughUniversity of Toronto
Trevor J PughOntario Institute for Cancer Research
Suzanne TrudelPrincess Margaret Cancer Centre, University Health Network
Suzanne TrudelUniversity of Toronto
Suzanne TrudelPrincess Margaret Cancer Centre, University Health Network
Suzanne TrudelUniversity of Toronto
  • 1 - 11

Datasets

Release 1.2